Magnevist (Page 5 of 6)
Medication Guide
MAGNEVIST (gadopentetate dimeglumine) |
What is Magnevist?
|
What is the most important information I should know about Magnevist?
|
Do not receive Magnevist if you have had a severe allergic reaction to Magnevist. |
Before receiving Magnevist, tell your healthcare provider about all your medical conditions, including if you:
|
What are the possible side effects of Magnevist?
The most common side effects of Magnevist include: headache, nausea, injection site coldness/localized coldness, and dizziness. These are not all the possible side effects of Magnevist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. |
General information about the safe and effective use of MAGNEVIST. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. You can ask your healthcare provider for information about MAGNEVIST that is written for health professionals. |
What are the ingredients in Magnevist? Active ingredient: gadopentetate dimeglumine Inactive ingredients: meglumine, meglumine pentetate, and water for injection Manufactured for Bayer HealthCare Pharmaceuticals Inc. Manufactured in Germany © 1988, Bayer HealthCare Pharmaceuticals Inc. All rights reserved. For more information, go to www.magnevist.com or call 1-888-842-2937. This Medication Guide has been approved by the U.S. Food and Drug Administration. Rev. 4/2018 |
Package/Label Display Panel: Vial 5 mL
NDC 50419-188-81
10 x 5 mL
Rx only
sterile solution
Magnevist®
(brand of gadopentetate dimeglumine) injection
For intravenous administration.
Single-dose container.
Discard unused portion.
Each mL contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine and 0.40 mg diethylenetriamine pentaacetic acid.
Contains no antimicrobial preservative.
Protect from light. Store at controlled room temperature, between 15-30°C (59-86°F). DO NOT FREEZE.
Dosage: See package insert.
- •
- 10 x 5 mL
- •
- Injection
Package/Label Display Panel: Vial 10 mL
NDC 50419-188-82
10 x 10 mL
Rx only
sterile solution
Magnevist®
(brand of gadopentetate dimeglumine) injection
For intravenous administration.
Single-dose container.
Discard unused portion.
Each mL contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine and 0.40 mg diethylenetriamine pentaacetic acid.
Contains no antimicrobial preservative.
Protect from light.
Store at controlled room temperature, between 15-30°C (59-86°F). DO NOT FREEZE.
Dosage: See package insert.
- •
- 10 x 10 mL
- •
- Injection
Package/Label Display Panel: Vial 15 mL
NDC 50419-188-83
10 x 15 mL
Rx only
sterile solution
Magnevist®
(brand of gadopentetate dimeglumine) injection
For intravenous administration.
Single-dose container.
Discard unused portion.
Each mL contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine and 0.40 mg diethylenetriamine pentaacetic acid.
Contains no antimicrobial preservative.
Protect from light.
Store at controlled room temperature, between 15-30°C (59-86°F). DO NOT FREEZE.
Dosage: See package insert.
- •
- 10 x 15 mL
- •
- Injection
Package/Label Display Panel: Vial 20 mL
NDC 50419-188-84
10 x 20 mL
Rx only
sterile solution
Magnevist®
(brand of gadopentetate dimeglumine) injection
For intravenous administration.
Single-dose container.
Discard unused portion.
Each mL contains 469.01 mg gadopentetate dimeglumine, 0.99 mg meglumine and 0.40 mg diethylenetriamine pentaacetic acid.
Contains no antimicrobial preservative.
Protect from light.
Store at controlled room temperature, between 15-30°C (59-86°F). DO NOT FREEZE.
Dosage: See package insert.
- •
- 10 x 20 mL
- •
- Injection
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.